• Media type: E-Article
  • Title: Psychometric properties of the Norwegian version of the short form of The Problem Areas in Diabetes scale (PAID-5): a validation study
  • Contributor: Vislapuu, Maarja; Broström, Anders; Igland, Jannicke; Vorderstrasse, Allison; Iversen, Marjolein M
  • imprint: BMJ, 2019
  • Published in: BMJ Open
  • Language: English
  • DOI: 10.1136/bmjopen-2018-022903
  • ISSN: 2044-6055
  • Keywords: General Medicine
  • Origination:
  • Footnote:
  • Description: <jats:sec><jats:title>Objectives</jats:title><jats:p>To assess the psychometric properties of the short form of The Problem Areas in Diabetes scale (PAID-5) in Norwegian adult patients with type 1 or type 2 diabetes.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Cross-sectional survey design.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Participants (n=143) were included from three Western-Norway endocrinology outpatient clinics. Demographic and clinical data were collected in addition to questionnaires concerning diabetes-related distress, fear of hypoglycaemia, symptoms of depression, emotional well-being and perception of general health. Psychometric evaluation of the PAID-5 included confirming its postulated one-factor structure using confirmatory factor analysis (CFA) and assessing convergent validity, discriminant validity, internal consistency and test-retest reliability. The retest questionnaire was sent out 35±15 days after the initial assessment to those who agreed (n=117).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The CFA for the PAID-5 scale showed excellent one-factor structure, and there was high internal consistency (α=0.89) and good test-retest reliability (Intraclass Correlation Coefficient, ICC=0.81). The PAID-5 correlated positively with fear of hypoglycaemia (r=0.598) and depression (r=0.380) and negatively with emotional well-being (r=−0.363) and perception of general health (r=−0.420), thus satisfying convergent validity. Patients who had experienced episodes of serious hypoglycaemia in the past 6 months had a significantly higher PAID-5 mean score (7.5, SD=4.95) than those who had not had these episodes (5.0, SD=4.2 (p=0.043)).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The Norwegian PAID-5 was shown to be a reliable and valid short questionnaire for assessing diabetes-related distress among people with type 1 or type 2 diabetes. However, its ability to discriminate between groups needs to be tested further in larger samples. The PAID-5 scale can be a particularly valuable screening instrument in outpatient clinics, as its brevity makes it easy to use as a tool in patient-provider encounters. This short questionnaire is useful in the national diabetes registry or population cohort studies as it enables increased knowledge regarding the prevalence of diabetes-related distress.</jats:p></jats:sec>
  • Access State: Open Access